Physiology and biology of neuromuscular transmission in health and disease

Journal of Critical Care

Volumn 24, Issue 1, 2009, Pages 5-10

  Shear, Torin D ^a,b   Martyn, J A Jeevendra ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Acetylcholine; Acetylcholine receptor; Neuromuscular junction; Up regulation

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ATROPINE; CHOLINERGIC RECEPTOR; CHOLINESTERASE; CISATRACURIUM; DILTIAZEM; EDROPHONIUM; KETAMINE; MUSCLE RELAXANT AGENT; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; NIFEDIPINE; PHYSOSTIGMINE; PROCAINE; PYRIDOSTIGMINE; ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM; TACRINE; VERAPAMIL;

DEPOLARIZATION; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; GAS POISONING; HUMAN; MOTONEURON; MUSCLE CELL; MYASTHENIA GRAVIS; MYOPATHY; NERVE ENDING; NERVE POTENTIAL; NEUROMUSCULAR DISEASE; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NEUROTRANSMISSION; PROTEIN SECRETION; REVIEW; SCHWANN CELL; SYNAPSE;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ACTION POTENTIALS; BINDING, COMPETITIVE; CHOLINESTERASE INHIBITORS; HUMANS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR JUNCTION DISEASES; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RECEPTORS, CHOLINERGIC; SYNAPTIC POTENTIALS; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 61449090363     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2008.08.002     Document Type: Review

References (28)

1. Jonsson M., Wyon N., Lindahl S.G.E., et al. Neuromuscular blocking agents block carotid body neuronal nicotinic acetylcholine receptors. Eur J Pharmacol 497 (2004) 173-180
2. Jooste E., Zhang Y., and Emala C.W. Neuromuscular blocking agents' differential bronchoconstrictive potential in guinea pig airways. Anesthesiology 106 (2007) 762-763
3. Vizi E.S., and Lendvai B. Side effects of nondepolarizing muscle relaxants: relationship to their antinicotinic and antimuscarinic actions. Pharmacol Ther 73 (1997) 75-89
4. Cohen-Cory S. The developing synapse: construction and modulation of synaptic structures and circuits. Science 298 (2002) 770-776
5. Sanes J.R., and Lichtman J.W. Induction, assembly, maturation and maintenance of a post-synaptic apparatus. Nat Rev Neurosci 2 (2001) 791-805
6. Fraterman S., Khurana T.S., and Rubinstein N.A. Identification of acetylcholine receptor subunits differentially expressed in singly and multiply innervated fibers of extraocular muscles. Invest Ophthalmol Vis Sci 47 (2006) 3828
7. Betz W.J., Caldwell J.H., and Kinnamon S.C. Increased sodium conductance in the synaptic region of rate skeletal muscle fibres. J Physiol (London) 352 (1984) 189-202
8. Rich M.M. The control of neuromuscular transmission in health and disease. Neuroscientist 12 (2006) 134-142
9. Engel A.G. The therapy of congenital myasthenia syndromes. Neurotherapeutics 4 (2007) 252
10. Wang X., Engisch K.L., Li Y., et al. Decreased synaptic activity shifts the calcium dependence of release at the mammalian neuromuscular junction in vivo. J Neurosci 24 (2004) 10687-10692
11. Yu F.H., and Catterall W.A. Overview of the voltage-gated sodium channel family. Genome Biol 4 (2003) 207
12. Turton K., Chaddock J.A., and Acharya K.R. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci 27 (2002) 552-558
13. Schurch B. The role of botulinum toxin in neurourology. Drugs Today (Barc) 40 (2004) 205
14. Lowe N.J. Overview of botulinum neurotoxins. J Cosmet Laser Ther 9 Suppl 1 (2007) 11-16
15. Frick C.G., Richtsfeld M., Martyn J.A.J., et al. Long-term effects of botulinum toxin on neuromuscular function. Anesthesiology 106 (2007) 1139-1146
16. Lange D.J., Rubin M., Gelb D.J., et al. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve 14 (1991) 672-675
17. Sieburth D., Ch'ng Q., Kaplan J.M., et al. Systematic analysis of genes required for synapse structure and function. Nature 436 (2005) 510-517
18. Bigalke H., and Rummel A. Medical aspects of toxin weapons. Toxicology 214 (2005) 210-220
19. Baker D.J. Critical care requirements after mass toxic agent release. Crit Care Med 33 (2005) S64-S74
20. Martyn J.A.J., Fukushima Y., Yang H.S., et al. Muscle relaxants in burns, trauma, and critical illness. Int Anesthesiol Clin 44 (2006) 123-143
21. Martyn J.A.J., and Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 104 (2006) 158-169
22. Song Y., Panzer J.A., Balice-Gordon R.J., et al. Formation and plasticity of neuromuscular synaptic connections. Int Anesthesiol Clin 44 (2006) 145-178
23. Martyn J.A.J., White D.A., Gronert G.A., et al. Up- and down-regulation of skeletal muscle acetylcholine receptors. Anesthesiology 26 (1992) 872
24. Tsuneki H., Salas R., and Dani J.A. Mouse muscle denervation increases expression of alpha 7 nicotinic receptor with unusual pharmacology. J Physiol 547 (2003) 169-179
25. Wang H., Yu M., Tracey K.J., et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
26. Taylor P. Anticholinesterase agents. In: Bruton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman & Gilman's pharmacological basis of therapeutics. 11th Ed. (2006), McGraw-Hill Professional, New York, NY 201
27. Richtsfeld M., Blobner M., and Martyn J.A.J. Chronic administration of pyridostigmine leads to a myasthenia-like with down-regulation of acetylcholine receptors. Young Investigator Award for abstract to be presented at ASCCA at the ASA Annual Meeting, San Francisco, CA, October (2003)
28. de Boer H.D., Driessen J.J., Marcus M.A., et al. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 107 (2007) 239